The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125068223 12506822 3 F 2010 20160721 20160629 20160726 EXP US-ROCHE-1784121 ROCHE 0.00 F Y 49.94000 KG 20160726 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125068223 12506822 1 PS CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 Unknown Y 50722
125068223 12506822 2 C PREDNISONE. PREDNISONE 1 0
125068223 12506822 3 C SYNTHROID LEVOTHYROXINE SODIUM 1 0
125068223 12506822 4 C PROTONIX PANTOPRAZOLE SODIUM 1 0
125068223 12506822 5 C PANTOPRAZOLE PANTOPRAZOLE SODIUM 1 Unknown 0 20 MG QD
125068223 12506822 6 C MIRTAZAPINE. MIRTAZAPINE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125068223 12506822 1 Autoimmune hepatitis
125068223 12506822 2 Autoimmune hepatitis
125068223 12506822 3 Autoimmune thyroiditis
125068223 12506822 4 Gastrooesophageal reflux disease
125068223 12506822 5 Gastrooesophageal reflux disease

Outcome of event

Event ID CASEID OUTC COD
125068223 12506822 OT
125068223 12506822 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125068223 12506822 Acute respiratory distress syndrome
125068223 12506822 Alopecia
125068223 12506822 Asthenia
125068223 12506822 Asthma
125068223 12506822 Autoimmune hepatitis
125068223 12506822 Chronic obstructive pulmonary disease
125068223 12506822 Decreased appetite
125068223 12506822 Drug ineffective
125068223 12506822 Dyspepsia
125068223 12506822 Hiatus hernia
125068223 12506822 Hip fracture
125068223 12506822 Lung abscess
125068223 12506822 Malaise
125068223 12506822 Plasma cell myeloma
125068223 12506822 Pneumonia
125068223 12506822 Pulmonary fibrosis
125068223 12506822 Weight decreased
125068223 12506822 White blood cell count increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125068223 12506822 1 2009 2010 0